Alterations of Gut Microbiota in Pyogenic Liver Abscess Patients with and without Type 2 Diabetes Mellitus

被引:0
作者
Liu, Shanshan [1 ,2 ]
Ge, Xiaomeng [3 ]
Xu, Xizhan [4 ]
Zhang, Kang [1 ]
Lu, Xinxin [1 ]
机构
[1] Capital Med Univ, Beijing Tongren Hosp, Dept Lab Med, 1 Dongjiaomin Lane, Beijing 100730, Peoples R China
[2] Xuzhou Med Univ, Affiliated Lianyungang Hosp, Peoples Hosp Lianyungang 1, Dept Infect Management, Lianyungang, Jiangsu, Peoples R China
[3] Chinese Acad Sci, Inst Microbiol, Microbial Resources & Big Data Ctr, Beijing, Peoples R China
[4] Capital Med Univ, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing Tongren Eye Ctr, Beijing, Peoples R China
来源
INFECTION AND DRUG RESISTANCE | 2024年 / 17卷
关键词
Gut microbiota; Pyogenic liver abscess; type 2 diabetes mellitus; 16S rRNA sequencing; CLINICAL CHARACTERISTICS; EPIDEMIOLOGY; INFECTION; CHINA;
D O I
10.2147/IDR.S456423
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Purpose: The clinical manifestations of pyogenic liver abscess (PLA) vary between patients with and without diabetes mellitus (DM). However, the relationship between PLA and the gut microbiome remains unknown. This study analyzed the composition of gut microbiota in PLA patients with and without DM and healthy controls (HCs) with the goal of identifying potential reasons for the observed variations in clinical manifestations. Patients and Methods: Using 16S ribosomal RNA(16S rRNA) gene sequencing, we analyzed the compositions of gut microbiota in 32 PLA patients with DM, 32 PLA patients without DM, and 29 matched HCs. Results: In PLA patients with DM, the D-dimer level, fibrinogen degradation products, and thrombin time were significantly higher compared to the PLA patients without DM ( P < 0.05). The abundance and diversity of intestinal flora were reduced in both groups of PLA patients compared with the HCs ( P < 0.05). Specifically, the PLA patients with DM showed significant decreases in the relative abundances of Bacteroides, Blautia, Prevotella9 , and Faecalibacterium , whereas Enterococcus and Escherichia-Shigella were relatively more abundant ( P < 0.05). Compared to PLA patients without DM, those with DM had lower relative abundances of Lactobacillus and Klebsiella ( P < 0.05) and showed different bacterial flora, including Anaerosporobacter and Megamonas . Conclusion: PLA patients with DM exhibited more severe clinical manifestations of PLA compared to patients without DM. It is important to monitor blood coagulation in PLA patients with DM to prevent the development of thrombotic diseases. Additionally, PLA patients with DM exhibit distinct differences in the composition and diversity of their intestinal flora compared to both PLA patients without DM and HCs.
引用
收藏
页码:2149 / 2158
页数:10
相关论文
共 50 条
  • [41] The diversity of gut microbiota in type 2 diabetes with or without cognitive impairment
    Zhang, Yunyun
    Lu, Shourong
    Yang, Ying
    Wang, Zhuo
    Wang, Bin
    Zhang, Bingshan
    Yu, Jie
    Lu, Wenwei
    Pan, Mingluo
    Zhao, Jianxin
    Guo, Shenghua
    Cheng, Jin
    Chen, Xiaorong
    Hong, Kan
    Li, Gang
    Yu, Zhiming
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2021, 33 (03) : 589 - 601
  • [42] The Association of Targeted Gut Microbiota with Body Composition in Type 2 Diabetes Mellitus
    Hung, Wei-Chun
    Hung, Wei-Wen
    Tsai, Hui-Ju
    Chang, Chen-Chia
    Chiu, Yi-Wen
    Hwang, Shang-Jyh
    Kuo, Mei-Chuan
    Chen, Szu-Chia
    Dai, Chia-Yen
    Tsai, Yi-Chun
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2021, 18 (02): : 511 - 519
  • [43] Current understanding on gut microbiota on insulin resistance and Type 2 diabetes mellitus
    Soomro, Samreen
    Alrashidi, Lama Saud
    Almutairi, Marah
    Obaidullah, Shatha
    RAWAL MEDICAL JOURNAL, 2025, 50 (01): : 205 - 210
  • [44] Role of gut microbiota in the pathogenesis of type 2 diabetes mellitus (literature review)
    Koval, S. M.
    Snihurska, I. O.
    MEDICNI PERSPEKTIVI, 2021, 26 (04): : 22 - 30
  • [45] The relationship between gut microbiota and susceptibility to type 2 diabetes mellitus in rats
    Yongcheng An
    Hongyu Dai
    Yuhui Duan
    Long Cheng
    Lu Shi
    Changhao He
    Chen Wang
    Yinglan Lv
    Huimin Li
    Huilin Zhang
    Yan Huang
    Wanxin Fu
    Weiguang Sun
    Baosheng Zhao
    Chinese Medicine, 18
  • [46] THE NEW VIEWS ON THE STATE OF THE GUT MICROBIOTA IN OBESITY AND DIABETES MELLITUS TYPE 2
    Pokrovskaya, Elena, V
    Shamkhalova, Minara S.
    Shestakova, Marina, V
    DIABETES MELLITUS, 2019, 22 (03): : 253 - 262
  • [47] The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus
    Kootte, R. S.
    Vrieze, A.
    Holleman, F.
    Dallinga-Thie, G. M.
    Zoetendal, E. G.
    de Vos, W. M.
    Groen, A. K.
    Hoekstra, J. B. L.
    Stroes, E. S.
    Nieuwdorp, M.
    DIABETES OBESITY & METABOLISM, 2012, 14 (02) : 112 - 120
  • [48] The relationship between gut microbiota and susceptibility to type 2 diabetes mellitus in rats
    An, Yongcheng
    Dai, Hongyu
    Duan, Yuhui
    Cheng, Long
    Shi, Lu
    He, Changhao
    Wang, Chen
    Lv, Yinglan
    Li, Huimin
    Zhang, Huilin
    Huang, Yan
    Fu, Wanxin
    Sun, Weiguang
    Zhao, Baosheng
    CHINESE MEDICINE, 2023, 18 (01)
  • [49] Synbiotics and Gut Microbiota: New Perspectives in the Treatment of Type 2 Diabetes Mellitus
    Jiang, Haoran
    Cai, Miaomiao
    Shen, Boyuan
    Wang, Qiong
    Zhang, Tongcun
    Zhou, Xiang
    FOODS, 2022, 11 (16)
  • [50] Gut microbiota influence in type 2 diabetes mellitus (T2DM)
    Cunningham, A. L.
    Stephens, J. W.
    Harris, D. A.
    GUT PATHOGENS, 2021, 13 (01)